Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

A research team has unveiled the cause and molecular mechanism of chronic brain inflammation that results in repetitive ...

Recent research published in PLOS One revealed a key mechanism driving acute to chronic muscle pain and demonstrated how ...

Dr David Johnson discusses recent findings indicating that vitamin D deficiency may contribute to the development of various ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...

"Stacy is joining Upstream Bio at a pivotal time in our growth as we prepare to initiate a third clinical program for ...

The authors detail how a balanced microbiome (eubiosis) sustains immune tolerance and systemic health, while dysbiosis ...

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...